Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05996445 |
|---|---|
| Brief Title: | A Study of XmAb®662 as Monotherapy or in Combination With Pembrolizumab in Advanced Solid Tumors |
| First Submitted : | June 23, 2023 |
| First Submitted that Met QC Criteria : | August 10, 2023 |
| First Posted : | August 18, 2023 |
| Last Update Submitted that Met QC Criteria : | August 10, 2023 |
| Last Update Posted : | August 18, 2023 |